Form 4 · Statement of Changes in Beneficial Ownership · Filed 2026-09-11
Kalia Kumud Files Guardant Health (GH) Form 4 - September 11, 2026
Kalia Kumud sold 4.0K GH shares worth $632.2K in this Form 4 filing, reported to the SEC on 2026-09-11.
- Insider
- Kalia Kumud
- Issuer
- Guardant Health Inc. GH · NASDAQ
- Filed
- Period
- 2026-09-11
- Accession
- 0001927831-26-000022
- Source
- Official filing on sec.gov ↗
Transactions (1)
| Insider | Date | Type | Shares | Price | Value | Own |
|---|---|---|---|---|---|---|
| Kalia Kumud | 2026-09-11 | Sell | 4.0K | $158.05 | $632.2K | Direct |
| Net change | −4.0K | −$632.2K | ||||
About Guardant Health Inc.
Guardant Health Inc. is a precision oncology company that develops blood- and tissue-based tests, data sets, and analytics to support cancer detection and treatment decisions. Its product portfolio includes liquid biopsy tests for tumor mutation profiling, molecular residual disease monitoring, tissue-based genomic profiling, and colorectal cancer screening. The company’s solutions are used across clinical care and research settings to help identify biomarkers, track recurrence, and provide molecular insights from tumor-derived material. Guardant Health serves healthcare providers, laboratories, researchers, and life sciences partners in the United States and internationally, with a focus on noninvasive diagnostics and cancer monitoring. Headquartered in Palo Alto, California, Guardant Health plays a significant role in the growing market for precision medicine and advanced oncology diagnostics.
Track GH insider activity
Get alerted when Guardant Health Inc. executives buy or sell their shares.